Figure 3.
Aggregate data on physical infrastructure, instrumentation, and expertise assets. (A) Represents 44 high‐throughput screening facilities from 40 sites. (B) Represents 31 biobanks from 31 sites. (C) Represents 81 high‐end instruments from 36 sites as awarded through the NIH HEI grant program. (D) Represents 24 drug discovery centers from 23 sites.